Gregory B. Abbott
Directeur/Membre du Conseil chez AmideBio LLC
Profil
Gregory B.
Abbott is currently the Director at AmideBio LLC and an Attorney at State of Washington.
Previously, he was the President & Chief Executive Officer at Synergen, Inc. and Darwin Molecular Corp.
He also served as a Director at diaDexus, Inc. and Selectide Corp.
In addition, he worked as a Principal at Cooley Godward LLP and Holme Roberts & Owen LLP.
Abbott received his undergraduate degree from Yale University and his graduate degree from the University of Denver.
Postes actifs de Gregory B. Abbott
| Sociétés | Poste | Début |
|---|---|---|
| State of Washington | Conseiller Juridique Général | - |
AmideBio LLC
 AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Directeur/Membre du Conseil | - |
Anciens postes connus de Gregory B. Abbott
| Sociétés | Poste | Fin |
|---|---|---|
| Holme Roberts & Owen LLP | Corporate Officer/Principal | 06/12/2011 |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Corporate Officer/Principal | 22/02/2008 |
Selectide Corp.
 Selectide Corp. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Selectide Corp. is a pharmaceutical research firm. The company is based in Tucson, AZ. The company was founded by Stephen Ralfe Evans-Freke. Selectide was acquired by Marion Merrell Dow, Inc. on January 27, 1995 for $58 million. | Directeur/Membre du Conseil | - |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Directeur/Membre du Conseil | - |
Darwin Molecular Corp
 Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | President | - |
Formation de Gregory B. Abbott
| University of Denver | Graduate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cooley Godward LLP
Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Commercial Services |
| Holme Roberts & Owen LLP | Commercial Services |
| State of Washington | Government |
| Synergen, Inc. | Utilities |
Darwin Molecular Corp
Darwin Molecular Corp Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million. | Commercial Services |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Selectide Corp.
Selectide Corp. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Selectide Corp. is a pharmaceutical research firm. The company is based in Tucson, AZ. The company was founded by Stephen Ralfe Evans-Freke. Selectide was acquired by Marion Merrell Dow, Inc. on January 27, 1995 for $58 million. | Commercial Services |
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Health Technology |
